NCT06833658Completed
Effects of Aromatherapy With Essential Oils on Anxiety and Depression in Perioperative Patients With Pancreatic Cancer
Source: ClinicalTrials.gov · Last updated 28 Sept 2026
Brief summary (registry, in English)
The objective of this study is to investigate whether aromatherapy essential oils are effective in alleviating anxiety and depression in participants undergoing perioperative pancreatic cancer treatment. Researchers compared aromatherapy essential oils with a placebo (a substance that appears similar but contains no essential oils) to determine their efficacy in reducing anxiety and depression in these participants. Participants were required to undergo aromatherapy for 2 hours daily over a period of 15 days. Assessments of anxiety and depression were conducted one day before surgery, 14 days after surgery, and 42 days after surgery, with their scores recorded accordingly.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 156 (actual)
- First submitted
- 12 Dec 2024
- Start date
- 1 Sept 2024
- Primary completion date
- 3 Aug 2025
- Lead sponsor
- Peking University First Hospital
- Diseases
- Pancreatic cancer
- NCT number
- NCT06833658
What you commit to
- Study type: Interventional
- Participants enrolled: 156
- From 1 Sept 2024 to the primary completion date, 3 Aug 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of mental illness or cognitive impairment
- Severe liver/kidney disease, cardiopulmonary dysfunction, tumor recurrence/metastasis
- Allergy or intolerance to aromatic reagents, olfactory disorders, acute respiratory disease, serious complications (unstable vital signs, blood clotting disorders, irreversible metabolic diseases)
- Termination due to disease treatment or condition changes
Other
- Poor compliance with study protocol or participation in similar studies
- Withdrawal for personal reasons
- Deemed unsuitable by investigator.
Who the study is looking for
- Meet diagnostic criteria in Chinese Anti-Cancer Association Guidelines for pancreatic cancer
- Age ≥18 years
- Contraception required, non-lactation period
- Consistent with surgical indications
- Surgical procedures: pancreaticoduodenectomy, extended pancreaticoduodenectomy, costocaudectomy, total pancreatectomy, subtotal pancreatectomy, pyloric-sparing pancreaticoduodenectomy
- Elective surgery without preoperative radiotherapy or chemotherapy
- Normal communication
- Preoperative SAS score ≥50 or SDS score ≥53
- Informed consent from subject or guardian
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Peking University First Hospital consecutively Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.